NASDAQ:ATNX - Athenex, Inc.
$20.00
 $0.02
+0.10%
4:00PM EDT
2019-07-15
Athenex, Inc. is an oncology pharmaceutical company focused on the development and commercialization of therapies for cancer diseases and supportive therapies. The Company's technology platform is organized into three categories, including Oral Absorption Platform, Src Kinase Inhibitors and Symptom Therapeutics. The Company's business includes medical technology centers and a manufacturing supply chain across both China and North America. The Company has approximately 10 products under development throughout the world with multiple offices in China and the United States.The Company's delivery system (P-glycoprotein (P-gp) pump inhibitor), is a technology platform, which enables oral absorption of a range of anticancer drugs and are given intravenously due to poor oral absorption. It offers Oraxol, an oral formulation of paclitaxel used for the treatment of breast, lung, ovarian and pancreatic cancer. It also offers Orateacan, an oral formulation of Irinotecan, which is delivered intravenously to treat colorectal cancer. The Company's Oradoxel is an oral formulation of Docetaxel, which is used to treat head and neck, gastric, breast, prostate and non-small cell lung cancers. Read more at  reuters.com
sector:  health care
industry:  biotechnology
the data below are updated and published after 9pm EDT each trading day
  ATNX     avg for
industry  
  avg for
sector  
42 stocks weight:  111. 28   114. 77   204. 78  
42 stocks rank:  1. 34 K 1. 44 K 810. 33  
# analyst opinions:  8. 00   13. 59   13. 86  
mean recommendation:  1. 80   2. 12   2. 04  

quick ratio:  1. 76   5. 48   1. 89  
current ratio:  2. 22   5. 85   2. 40  

target price low:  15. 50   82. 72   115. 11  
target price avg:  25. 23   104. 42   138. 02  
target price high:  38. 00   130. 64   159. 47  
1-yr high:  21. 00   110. 27   142. 72  
last close:  19. 98   85. 12   126. 54  
50-day avg:  16. 09   86. 06   122. 35  
200-day avg:  13. 30   88. 76   121. 75  
1-yr low:  9. 44   69. 26   100. 63  
volume:  333. 05 K 3. 51 M 5. 53 M
50-day avg volume:  678. 35 K 3. 21 M 4. 22 M
200-day avg volume:  391. 51 K 3. 04 M 4. 75 M

1-day return:  -0. 45 % -0. 30 % -1. 01 %
this week return:  1. 94 % -2. 16 % -1. 35 %
12-wk return:  80. 65 % 3. 34 % 8. 69 %
52-wk return:  12. 66 % -1. 76 % 12. 22 %

enterprise value (EV):  1. 38 B 46. 50 B 123. 99 B
market cap:  1. 54 B 40. 77 B 109. 11 B
EBITDA:  -149. 62 M 4. 33 B 8. 19 B
enterprise multiple (EV/EBITDA):  -9. 25   5. 45   12. 05  
enterprise/revenue (EV/R):  18. 08   50. 46   9. 50  
total revenue:  76. 57 M 10. 21 B 40. 60 B
total debt:  59. 16 M 11. 27 B 17. 58 B
debt/equity:  61. 90   57. 36   120. 25  
net income (common):  -145. 38 M 2. 13 B 4. 27 B

shares outstanding:  67. 06 M 551. 08 M 1. 24 B
shares:  40. 03 M 559. 41 M 1. 22 B
shares short:  5. 21 M 11. 15 M 11. 94 M
shares short prior month:  5. 68 M 9. 31 M 11. 96 M
short ratio:  9. 44   5. 72   3. 43  
short % of float:  8. 86 % 6. 40 % 2. 65 %
total cash/share:  1. 06   11. 00   9. 23  
total cash:  71. 34 M 6. 03 B 6. 01 B
free cash flow:  -109. 12 M 3. 02 B 4. 96 B
operating cash flow:  -129. 63 M 3. 92 B 5. 99 B

book value:  1. 60   13. 02   27. 49  
price/book:  12. 50   4. 21   8. 80  
gross profits:  -77. 51 M 7. 67 B 36. 29 B
operating margins:  -199. 69 % -380. 20 % -38. 44 %
EBITDA margins:  -195. 41 % 13. 59 % 23. 24 %
profit margins:  -189. 86 % 10. 94 % 14. 00 %
gross margins:  -132. 93 % 36. 11 % 55. 16 %

1-yr max volatility:  28. 31 % --- ---
1-yr mean volatility:  2. 47 % 1. 50 % 1. 08 %

1-yr EPS:  -2. 21   2. 12   4. 26  
forward EPS:  -1. 37   3. 47   7. 14  
P/E:  -9. 06   2. 15   33. 17  
forward P/E:  -14. 65   -4. 03   17. 60  
PE/G:  0. 27   0. 54   0. 34  
growth:  -33. 10 % 263. 03 % 78. 34 %
earnings high:  -0. 17   0. 91   1. 70  
earnings avg:  -0. 37   0. 71   1. 58  
earnings low:  -0. 50   0. 48   1. 46  
revenue high:  35. 14 M 2. 64 B 11. 26 B
revenue avg:  21. 33 M 2. 58 B 11. 09 B
revenue low:  15. 10 M 2. 54 B 10. 90 B
return on assets:  -45. 74 % -2. 31 % 5. 31 %
return on equity:  -125. 25 % -82. 48 % 135. 30 %
revenue growth:  -33. 10 % 262. 60 % 72. 94 %
revenue/share:  1. 16   12. 77   61. 38  

beta (1yr vs S&P500):  1. 50   1. 26   0. 91  
sharpe (1yr):  0. 41   0. 07   0. 77  

held % insiders:  31. 44 % 6. 08 % 3. 31 %
held % institutions:  32. 25 % 78. 36 % 69. 61 %

Research more with google or yahoo!
the data below are updated and re-published at 8pm EDT after each trading day

2019-07-14 : ATNX
.    128.204 =       128.204 :: --> INITIAL WEIGHT <--
.    - 2.205 =       125.999 :: earnings per-share addition
.                               --> FUNDAMENTALS <--
.    x 2.185 =       275.264 :: P/E factor
.    x 1.382 =       380.548 :: PE/G factor
.    x 1.606 =       611.308 :: beta factor
.    x 0.786 =       480.545 :: sharpe factor
.     x 2.38 =      1143.661 :: current ratio factor
.    x 1.466 =      1676.683 :: quick ratio factor
.    x 1.052 =      1763.255 :: short ratio factor
.    x 1.358 =      2395.137 :: EV/R factor
.    x 1.125 =      2694.948 :: price-to-book factor
.    x 1.294 =      3488.021 :: debt-to-revenue factor
.    x 1.386 =      4834.247 :: debt-to-equity factor
.                               --> PERFORMANCE <--
.    x 2.114 =     10219.523 :: sector+industry 1-year gains factor
.    x 1.033 =     10560.835 :: industry 12-weeks return factor
.    x 1.305 =      13784.78 :: industry 2-weeks return factor
.    x 1.072 =     14775.746 :: company one-year gains+dividend factor
.    x 3.671 =     54243.231 :: company 13 weeks' performance factor
.    x 2.094 =    113575.318 :: 5-day avg > 200-day avg
.    x 2.172 =    246654.093 :: 5-day avg > 50-day avg
.    x 1.209 =    298324.174 :: 50-day avg > 200-day avg
.    x 0.984 =    293420.525 :: "drift" penalty 1 days ago
.    x 0.977 =    286558.537 :: "drift" penalty 4 days ago
.    / 1.954 =    146659.976 :: overall "drift" factor
.     x 0.85 =    124671.194 :: largest single-day jump factor
.    x 0.991 =    123551.166 :: volatility factor
.    x 0.993 =    122645.375 :: 42-day volatility factor
.     x 2.05 =    251396.908 :: notable returns + performance factor
.    x 2.528 =    635480.295 :: performance vs s&p500 factor
.    x 3.108 =   1974782.694 :: inverse volume-to-price factor
.                               --> PROJECTIONS <--
.    x 0.905 =   1786486.771 :: forward EPS factor
.    x 0.965 =   1724587.903 :: forward P/E factor
.    x 1.182 =   2039236.993 :: industry recommendation factor
.    x 2.515 =   5129180.828 :: company recommendation factor
.    x 1.008 =   5168410.554 :: factor historical industry gain for week 28
.    x 0.928 =   4794894.862 :: target low factor
.    x 1.171 =   5614188.804 :: target mean factor
.     x 1.04 =   5838120.699 :: target high factor
.   x 10.296 =  60106843.166 :: spline projection factor
.                               --> FINAL ADJUSTMENTS <--
.  quad root =         88.05 :: reduced for readability
.   + 23.234 =       111.284 :: add/subtract for investor sentiment
.                               --> FINAL WEIGHT <--
.                    111.284 :: FINAL WEIGHT for NASDAQ:ATNX


 


News feed RSS items generated from finance.google.com

News feed formatting by feed2js.org